Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Cancer Registry Software Market Size study, by Type (Standalone Software, Integrated Software), by Deployment Model (On-Premise, Cloud-Based), by Database Type (Commercial Database, Public Database), By Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research & Clinical Studies, Product Outcome Evaluation), by End-User (Government Organizations & Third-Party Administrators, Hospitals & Medical Practices, Private Players, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers) and Regional Forecasts 2019-2026

  • BIZ3318722
  • 200 Pages
  • November 2019
  • Healthcare
Download Sample    Get Discount   
 
Global Cancer Registry Software Market is valued approximately at USD 50.68 million in 2018 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2019-2026. Cancer registry is a computerized database which uses software solutions to organize, gather and store data of the cancer patients and evaluate cancer-specific upshots, situations and drug/medical device exposure. Growing number of cancer cases, increasing adoption of EHR, favorable government programs towards cancer and growing use of cancer patient registry data for post-marketing surveillance are the few factors responsible for high CAGR of the market over the forecast period. For instance, In 2018, it was estimated that there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Owing to Tthe prevalence of cancer is on surging trend thereby escalating, the need for cancer registry software is also increased all over the world. Moreover, increasing number of accountable care organizations and growth of cloud-based cancer patient registry solutions is the major factor likely to create lucrative growth opportunity to the market in the upcoming years. However, privacy and data security-related concerns is one of the major factors anticipated to limiting the growth of global cancer registry software market during the forecast period.

The regional analysis of global Cancer Registry Software Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer, government funding initiatives to encourage the development of cancer registries and high investments in healthcare IT across the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026.

Major market player included in this report are:

Onco, Inc.

C/Net Solutions

Elekta AB (PUB)

Rocky Mountain Cancer Data Systems

Electronic Registry Systems, Inc.

MckessonMcKesson Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Standalone Software

Integrated Software

By Deployment Model:

On-premise

Cloud-Based

By Database Type:

Commercial Database

Public Database

By Functionality:

Cancer Reporting to Meet State and Federal Regulations

Patient Care Management

Medical Research & Clinical Studies

Product Outcome Evaluation

By End-User:

Government Organizations & Third-Party Administrators

Hospitals & Medical Practices

Private Players

Pharmaceutical, Biotechnology, and Medical Device Companies

Research Centers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Cancer Registry Software Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)

1.2.1. Cancer Registry Software Market, by Type, 2017-2026 (USD Million)

1.2.2. Cancer Registry Software Market, by Deployment Model, 2017-2026 (USD Million)

1.2.3. Cancer Registry Software Market, by Database Type, 2017-2026 (USD Million)

1.2.4. Cancer Registry Software Market, by Functionality, 2017-2026 (USD Million)

1.2.5. Cancer Registry Software Market, by End-User, 2017-2026 (USD Million)

1.2.6. Cancer Registry Software Market, by Region, 2017-2026 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Cancer Registry Software Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Cancer Registry Software Market Dynamics

3.1. Cancer Registry Software Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Cancer Registry Software Market Type Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Registry Software Market, by Type

5.1. Market Snapshot

5.2. Global Cancer Registry Software Market by Type, Performance - Potential Analysis

5.3. Global Cancer Registry Software Market Estimates & Forecasts by Type 2016-2026 (USD Million)

5.4. Cancer Registry Software Market, Sub Segment Analysis

5.4.1. Standalone Software

5.4.2. Integrated Software

Chapter 6. Global Cancer Registry Software Market, by Deployment Model

6.1. Market Snapshot

6.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis

6.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)

6.4. Cancer Registry Software Market, Sub Segment Analysis

6.4.1. On-premises

6.4.2. Cloud-based

Chapter 7. Global Cancer Registry Software Market, by Database Type

7.1. Market Snapshot

7.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis

7.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)

7.3.1. Commercial Databases

7.3.2. Public Databases

Chapter 8. Global Cancer Registry Software Market, by Functionality

8.1. Market Snapshot

8.2. Global Cancer Registry Software Market by Functionality, Performance - Potential Analysis

8.3. Global Cancer Registry Software Market Estimates & Forecasts by Functionality, 2016-2026 (USD Million)

8.3.1. Cancer Reporting to Meet State and Federal Regulations

8.3.2. Patient Care Management

8.3.3. Medical Research & Clinical Studies

8.3.4. Product Outcome Evaluation

Chapter 9. Global Cancer Registry Software Market, by End-User

9.1. Market Snapshot

9.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis

9.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)

9.3.1. Government Organizations & Third-Party Administrators

9.3.2. Hospitals & Medical Practices

9.3.3. Private Payers

9.3.4. Pharmaceutical, Biotechnology, and Medical Device Companies

9.3.5. Research Centers

Chapter 10. Global Cancer Registry Software Market, Regional Analysis

10.1. Cancer Registry Software Market, Regional Market Snapshot

10.2. North America Cancer Registry Software Market

10.2.1. U.S. Cancer Registry Software Market

10.2.1.1. Type breakdown estimates & forecasts, 2016-2026

10.2.1.2. Deployment Model breakdown estimates & forecasts, 2016-2026

10.2.1.3. Database Type breakdown estimates & forecasts, 2016-2026

10.2.1.4. Functionality breakdown estimates & forecasts, 2016-2026

10.2.1.5. End-User breakdown estimates & forecasts, 2016-2026

10.2.2. Canada Cancer Registry Software Market

10.3. Europe Cancer Registry Software Market Snapshot

10.3.1. U.K. Cancer Registry Software Market

10.3.2. Rest of Europe Cancer Registry Software Market

10.4. Asia-Pacific Cancer Registry Software Market Snapshot

10.4.1. China Cancer Registry Software Market

10.4.2. India Cancer Registry Software Market

10.4.3. Japan Cancer Registry Software Market

10.4.4. Rest of Asia Pacific Cancer Registry Software Market

10.5. Latin America Cancer Registry Software Market Snapshot

10.5.1. Brazil Cancer Registry Software Market

10.5.2. Mexico Cancer Registry Software Market

10.6. Rest of The World Cancer Registry Software Market

Chapter 11. Competitive Intelligence

11.1. Top Market Strategies

11.2. Company Profiles

11.2.1. Onco, Inc.

11.2.1.1. Key Information

11.2.1.2. Overview

11.2.1.3. Financial (Subject To Data Availability)

11.2.1.4. Product Summary

11.2.1.5. Recent Developments

11.2.2. C/Net Solutions

11.2.3. Elekta AB (PUB)

11.2.4. Rocky Mountain Cancer Data Systems

11.2.5. Electronic Registry Systems, Inc.

11.2.6. Mckesson Corporation

Chapter 12. Research Process

12.1. Research Process

12.1.1. Data Mining

12.1.2. Analysis

12.1.3. Market Estimation

12.1.4. Validation

12.1.5. Publishing

12.2. Research Attributes

12.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET

TABLE 3. GLOBAL CANCER REGISTRY SOFTWARE MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)

TABLE 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD MILLION)

TABLE 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DEPLOYMENT MODEL 2016-2026 (USD MILLION)

TABLE 9. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DATABASE TYPE 2016-2026 (USD MILLION)

TABLE 10. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY FUNCTIONALITY 2016-2026 (USD MILLION)

TABLE 11. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)

TABLE 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 13. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 14. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 15. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 16. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 17. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 18. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 19. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 20. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 21. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 22. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 23. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 24. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 25. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 26. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 27. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 28. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 29. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 30. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 31. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 32. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 33. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 34. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 35. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 36. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 37. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 38. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 39. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 40. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 41. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 42. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 43. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 44. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 45. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 46. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 47. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 48. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 49. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 50. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 51. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 52. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 53. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 54. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 55. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 56. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 57. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 58. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 59. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 60. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 61. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 62. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 63. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 64. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 65. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 66. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 67. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 68. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 69. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 70. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 71. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 72. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 73. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 74. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 75. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 76. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 77. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 78. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 79. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 80. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 81. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 82. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 83. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 84. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 85. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 86. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 87. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 88. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 89. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 90. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 91. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 92. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 93. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 94. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 95. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 96. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 97. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 98. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 99. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 100. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 101. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 102. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 103. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 104. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research